CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C29304 | BRD-K84724939 | BRD-K84724939 | -- | -- | -- | Details |
C29305 | BRD-K84733605 | BRD-K84733605 | -- | -- | -- | Details |
C29306 | BRD-K84738609 | BRD-K84738609 | -- | -- | -- | Details |
C29307 | BRD-K84739463 | BRD-K84739463 | -- | -- | -- | Details |
C29308 | BRD-K84741596 | BRD-K84741596 | -- | -- | -- | Details |
C29309 | BRD-K84745303 | BRD-K84745303 | -- | -- | -- | Details |
C29310 | BRD-K84748119 | vicriviroc | CCR5 | CCK receptor antagonist | -- | Details |
C29311 | BRD-K84749975 | BRD-K84749975 | -- | -- | -- | Details |
C29312 | BRD-K84754008 | CBB-1007 | -- | -- | -- | Details |
C29313 | BRD-K84761515 | BRD-K84761515 | -- | -- | -- | Details |
C29314 | BRD-K84762162 | BRD-K84762162 | -- | -- | -- | Details |
C29315 | BRD-K84769529 | BRD-K84769529 | -- | -- | -- | Details |
C29316 | BRD-K84770158 | BRD-K84770158 | -- | -- | -- | Details |
C29317 | BRD-K84770507 | BRD-K84770507 | -- | -- | -- | Details |
C29318 | BRD-K84770655 | BRD-K84770655 | -- | -- | -- | Details |
C29319 | BRD-K84775364 | BRD-K84775364 | -- | -- | -- | Details |
C29320 | BRD-K84783599 | riociguat | GUCY1A1; GUCY1B1 | Guanylate cyclase stimulant | -- | Details |
C29321 | BRD-K84787606 | BRD-K84787606 | -- | -- | -- | Details |
C29322 | BRD-K84788922 | BRD-K84788922 | -- | -- | -- | Details |
C29323 | BRD-K84790105 | BRD-K84790105 | -- | -- | -- | Details |
C29324 | BRD-K84792324 | BRD-K84792324 | -- | -- | -- | Details |
C29325 | BRD-K84792586 | BRD-K84792586 | -- | -- | -- | Details |
C29326 | BRD-K84794093 | dideoxyadenosine | -- | -- | -- | Details |
C29327 | BRD-K84794783 | BRD-K84794783 | -- | -- | -- | Details |
C29328 | BRD-K84797651 | BRD-K84797651 | -- | -- | -- | Details |
C29329 | BRD-K84797952 | BRD-K84797952 | -- | -- | -- | Details |
C29330 | BRD-K84798689 | BRD-K84798689 | -- | -- | sodium-tanshinone-ii-a-sulfonate | Details |
C29331 | BRD-K84800135 | BRD-K84800135 | -- | -- | -- | Details |
C29332 | BRD-K84802956 | BRD-K84802956 | -- | -- | -- | Details |
C29333 | BRD-K84803513 | BRD-K84803513 | -- | -- | -- | Details |
C29334 | BRD-K84807441 | BRD-K84807441 | -- | -- | -- | Details |
C29335 | BRD-K84810405 | almorexant | HCRTR1; HCRTR2 | Orexin receptor antagonist | -- | Details |
C29336 | BRD-K84815485 | BRD-K84815485 | -- | -- | -- | Details |
C29337 | BRD-K84821804 | BRD-K84821804 | -- | -- | -- | Details |
C29338 | BRD-K84831408 | BRD-K84831408 | -- | -- | -- | Details |
C29339 | BRD-K84832762 | BRD-K84832762 | -- | -- | -- | Details |
C29340 | BRD-K84836394 | BRD-K84836394 | -- | -- | -- | Details |
C29341 | BRD-K84836616 | BRD-K84836616 | -- | -- | -- | Details |
C29342 | BRD-K84838433 | BRD-K84838433 | -- | -- | -- | Details |
C29343 | BRD-K84846130 | BRD-K84846130 | -- | -- | -- | Details |
C29344 | BRD-K84853311 | BRD-K84853311 | -- | -- | -- | Details |
C29345 | BRD-K84855052 | BRD-K84855052 | -- | -- | -- | Details |
C29346 | BRD-K84855138 | BRD-K84855138 | -- | -- | -- | Details |
C29347 | BRD-K84856528 | BRD-K84856528 | -- | -- | -- | Details |
C29348 | BRD-K84858116 | BRD-K84858116 | -- | -- | -- | Details |
C29349 | BRD-K84860580 | SA-86418 | -- | -- | -- | Details |
C29350 | BRD-K84864079 | BRD-K84864079 | -- | -- | -- | Details |
C29351 | BRD-K84874502 | BRD-K84874502 | -- | -- | -- | Details |
C29352 | BRD-K84874839 | BRD-K84874839 | -- | -- | -- | Details |
C29353 | BRD-K84876223 | BRD-K84876223 | -- | -- | -- | Details |
C29354 | BRD-K84879982 | BRD-K84879982 | -- | -- | -- | Details |
C29355 | BRD-K84881516 | BRD-K84881516 | -- | -- | -- | Details |
C29356 | BRD-K84890987 | BRD-K84890987 | -- | -- | -- | Details |
C29357 | BRD-K84892605 | IOWH-032 | -- | -- | -- | Details |
C29358 | BRD-K84895041 | BMY-45778 | PTGIR | IP receptor activator | -- | Details |
C29359 | BRD-K84907327 | BRD-K84907327 | -- | -- | -- | Details |
C29360 | BRD-K84909597 | BRD-K84909597 | -- | -- | -- | Details |
C29361 | BRD-K84921800 | BRD-K84921800 | -- | -- | -- | Details |
C29362 | BRD-K84924563 | BRD-K84924563 | -- | -- | -- | Details |
C29363 | BRD-K84925803 | T-5224 | JUN | AP inhibitor | -- | Details |
C29364 | BRD-K84932026 | BRD-K84932026 | -- | -- | -- | Details |
C29365 | BRD-K84934330 | acrylonitrile | -- | -- | -- | Details |
C29366 | BRD-K84935204 | BRD-K84935204 | -- | -- | -- | Details |
C29367 | BRD-K84935293 | BRD-K84935293 | -- | -- | -- | Details |
C29368 | BRD-K84935712 | BRD-K84935712 | -- | -- | -- | Details |
C29369 | BRD-K84935903 | BRD-K84935903 | -- | -- | -- | Details |
C29370 | BRD-K84936524 | BRD-K84936524 | -- | -- | -- | Details |
C29371 | BRD-K84937637 | sirolimus | FKBP1A; MTOR | MTOR inhibitor | -- | Details |
C29372 | BRD-K84939696 | BRD-K84939696 | -- | -- | -- | Details |
C29373 | BRD-K84943004 | MC-1293 | -- | -- | -- | Details |
C29374 | BRD-K84949119 | BRD-K84949119 | -- | -- | -- | Details |
C29375 | BRD-K84951011 | BRD-K84951011 | -- | -- | -- | Details |
C29376 | BRD-K84955386 | hyperoside | -- | -- | -- | Details |
C29377 | BRD-K84956158 | BRD-K84956158 | -- | -- | -- | Details |
C29378 | BRD-K84959002 | BRD-K84959002 | -- | -- | -- | Details |
C29379 | BRD-K84963986 | BRD-K84963986 | -- | -- | -- | Details |
C29380 | BRD-K84971356 | etafenone | -- | -- | -- | Details |
C29381 | BRD-K84974041 | BRD-K84974041 | -- | -- | -- | Details |
C29382 | BRD-K84975143 | BRD-K84975143 | -- | -- | -- | Details |
C29383 | BRD-K84976438 | SA-1458450 | -- | -- | -- | Details |
C29384 | BRD-K84986517 | darunavir | CYP3A4 | HIV protease inhibitor | -- | Details |
C29385 | BRD-K84987553 | MDM2-inhibitor | MDM2 | MDM inhibitor | MDM-2-INHIBITOR | Details |
C29386 | BRD-K84988480 | BRD-K84988480 | -- | -- | -- | Details |
C29387 | BRD-K84990603 | BRD-K84990603 | -- | -- | -- | Details |
C29388 | BRD-K84992272 | BRD-K84992272 | -- | -- | -- | Details |
C29389 | BRD-K84994827 | BRD-K84994827 | -- | -- | -- | Details |
C29390 | BRD-K84996356 | AZD-3514 | -- | -- | -- | Details |
C29391 | BRD-K84996949 | sinensetin | -- | -- | -- | Details |
C29392 | BRD-K85007671 | BRD-K85007671 | -- | -- | -- | Details |
C29393 | BRD-K85013741 | auraptene | MAOB | Nitric oxide production inhibitor | -- | Details |
C29394 | BRD-K85014146 | AZD-2461 | -- | -- | -- | Details |
C29395 | BRD-K85015012 | NNC-05-2090 | SLC6A12 | GAT inhibitor; GABA uptake inhibitor | -- | Details |
C29396 | BRD-K85025453 | BRD-K85025453 | -- | -- | -- | Details |
C29397 | BRD-K85030001 | SA-1456625 | -- | -- | -- | Details |
C29398 | BRD-K85030058 | benactyzine | -- | -- | -- | Details |
C29399 | BRD-K85044233 | BRD-K85044233 | -- | -- | -- | Details |
C29400 | BRD-K85051145 | BRD-K85051145 | -- | -- | -- | Details |
C29401 | BRD-K85051645 | BRD-K85051645 | -- | -- | -- | Details |
C29402 | BRD-K85055578 | BRD-K85055578 | -- | -- | -- | Details |
C29403 | BRD-K85055995 | BRD-K85055995 | -- | -- | -- | Details |